| pubmed-article:3359404 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3359404 | lifeskim:mentions | umls-concept:C0024291 | lld:lifeskim |
| pubmed-article:3359404 | lifeskim:mentions | umls-concept:C0019623 | lld:lifeskim |
| pubmed-article:3359404 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:3359404 | lifeskim:mentions | umls-concept:C0696113 | lld:lifeskim |
| pubmed-article:3359404 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:3359404 | pubmed:dateCreated | 1988-6-7 | lld:pubmed |
| pubmed-article:3359404 | pubmed:abstractText | Serum ferritin level was measured serially in three malignant histiocytosis (MH) and five virus-associated hemophagocytic syndrome (VAHS) patients. Serum ferritin levels were greater than 1000 ng/ml at the early phase of disease. When disseminated intravascular coagulation (DIC) developed in patients, serum ferritin levels elevated further to greater than 12,000 ng/ml. MH patients were treated by combination chemotherapy, and VAHS patients were given prednisone. Each MH and VAHS patient died within 1 week from the onset of DIC, without decrease of serum ferritin level. One MH patient with continued high serum ferritin levels for 3 months after DIC also died. The remaining patients with decreased serum ferritin values less than 1000 ng/ml at 3 months after DIC are now alive with normal serum ferritin levels. These results suggest that serum ferritin level in histiocytic proliferative disorders is a useful indicator of disease activity in both neoplastic and reactive conditions rather than only a marker of malignant process. | lld:pubmed |
| pubmed-article:3359404 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3359404 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3359404 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:3359404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3359404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3359404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3359404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3359404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3359404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3359404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3359404 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3359404 | pubmed:month | May | lld:pubmed |
| pubmed-article:3359404 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:3359404 | pubmed:author | pubmed-author:ImashukuSS | lld:pubmed |
| pubmed-article:3359404 | pubmed:author | pubmed-author:TodoSS | lld:pubmed |
| pubmed-article:3359404 | pubmed:author | pubmed-author:IkushimaSS | lld:pubmed |
| pubmed-article:3359404 | pubmed:author | pubmed-author:HibiSS | lld:pubmed |
| pubmed-article:3359404 | pubmed:author | pubmed-author:EsumiNN | lld:pubmed |
| pubmed-article:3359404 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3359404 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:3359404 | pubmed:volume | 61 | lld:pubmed |
| pubmed-article:3359404 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3359404 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3359404 | pubmed:pagination | 2071-6 | lld:pubmed |
| pubmed-article:3359404 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:3359404 | pubmed:meshHeading | pubmed-meshheading:3359404-... | lld:pubmed |
| pubmed-article:3359404 | pubmed:meshHeading | pubmed-meshheading:3359404-... | lld:pubmed |
| pubmed-article:3359404 | pubmed:meshHeading | pubmed-meshheading:3359404-... | lld:pubmed |
| pubmed-article:3359404 | pubmed:meshHeading | pubmed-meshheading:3359404-... | lld:pubmed |
| pubmed-article:3359404 | pubmed:meshHeading | pubmed-meshheading:3359404-... | lld:pubmed |
| pubmed-article:3359404 | pubmed:meshHeading | pubmed-meshheading:3359404-... | lld:pubmed |
| pubmed-article:3359404 | pubmed:meshHeading | pubmed-meshheading:3359404-... | lld:pubmed |
| pubmed-article:3359404 | pubmed:meshHeading | pubmed-meshheading:3359404-... | lld:pubmed |
| pubmed-article:3359404 | pubmed:meshHeading | pubmed-meshheading:3359404-... | lld:pubmed |
| pubmed-article:3359404 | pubmed:meshHeading | pubmed-meshheading:3359404-... | lld:pubmed |
| pubmed-article:3359404 | pubmed:meshHeading | pubmed-meshheading:3359404-... | lld:pubmed |
| pubmed-article:3359404 | pubmed:meshHeading | pubmed-meshheading:3359404-... | lld:pubmed |
| pubmed-article:3359404 | pubmed:meshHeading | pubmed-meshheading:3359404-... | lld:pubmed |
| pubmed-article:3359404 | pubmed:meshHeading | pubmed-meshheading:3359404-... | lld:pubmed |
| pubmed-article:3359404 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:3359404 | pubmed:articleTitle | High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. | lld:pubmed |
| pubmed-article:3359404 | pubmed:affiliation | Department of Pediatrics, Kyoto Prefectural University of Medicine, Japan. | lld:pubmed |
| pubmed-article:3359404 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3359404 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3359404 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3359404 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3359404 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3359404 | lld:pubmed |
